Vor Ort
Merkzettel Warenkorb
Produktbild: Molecular Defects in Cardiovascular Disease
- 13%

Molecular Defects in Cardiovascular Disease

13% sparen

138,99 € UVP 160,49 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.08.2011

Abbildungen

XVIII, 382 p. 78 illus., 31 illus. in color.

Herausgeber

Naranjan S. Dhalla + weitere

Verlag

Springer Us

Seitenzahl

382

Maße (L/B/H)

26/18,3/2,5 cm

Gewicht

947 g

Sprache

Englisch

ISBN

978-1-4419-7129-6

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.08.2011

Abbildungen

XVIII, 382 p. 78 illus., 31 illus. in color.

Herausgeber

Verlag

Springer Us

Seitenzahl

382

Maße (L/B/H)

26/18,3/2,5 cm

Gewicht

947 g

Sprache

Englisch

ISBN

978-1-4419-7129-6

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Molecular Defects in Cardiovascular Disease

  • Calcium overloading-induced oxidative stress-mediated cellular and subcellular remodeling.- Intracellular MMP-2:  Role in normal and diseased hearts.- Control of the mesenchymal-derived cell phenotype by Ski and Meox2: A putative mechanism for post-developmental phenoconversion.- Elevated Na
    +
    /H
    +
    exchanger expression and its role in myocardial disease.- Impact of perinatal chronic hypoxia on cardiac tolerance to acute ischemia.- Stem cell, microRNA and redox cycling.- Cardiac cell therapy: Present and future.- Macroscopic and microscopic aspects of cardiac dysfunction in congestive heart failure.- Cardiac dysfunction and metabolism: Unravelling the molecular cross-talk.- Metabolic remodeling of the hypertrophied heart.- Mechanisms for the regulation of phospholipase C gene expression in cardiac hypertrophy.- Molecular changes in fatty acid oxidation in the failing heart.- Cardiolipin metabolism in experimental and human heart failure.- Mechanisms underlying development of cardiomyocyte hypertrophy
    via
    Na-H exchange stimulation.- The structural basis of cardiac dysfunction in human heart failure.- Hormonal mechanisms of cardiac remodeling in heart failure.- Modulators of remodeling after myocardial infarction.- Phosphodiesterase-5 inhibitors in protection against doxorubicin-induced cardiomyopathy.- Molecular basis of pulmonary hypertension in left heart failure.- Modulation of G
    i
    protein expression in hypertension: Molecular mechanisms.- Vascular dysfunction in heart disease.- Cellular and molecular mechanisms associated with salicylate inhibition of intimal hyperplasia balloon catheter-induced vascular injury.- Involvement of growth factor receptor and non receptor protein tyrosine kinases in endothelin 1 and angiotensin II-induced signaling pathways in the cardiovascular system.- Sarco/endoplasmic reticulum Ca
    2+
    pump damage by oxidative stress: Implications forCa
    2+
    entry.- Obesity-hypertension: Leptin as the common link to cardiovascular and renal dysregulation.- Cardiorenal protection in diabetes mellitus.- Molecular mechanisms in the pathogenesis of diabetic cardiomyopathy.